Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Hemp seed-derived exosomes help restore feather growth in chickens affected by DHT.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Understanding biological mediators in skin healing can improve treatments for skin wounds.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

These new skin treatments are safer and more effective with minimal side effects.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.